BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32881844)

  • 21. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha.
    Phillips RJ; Mestas J; Gharaee-Kermani M; Burdick MD; Sica A; Belperio JA; Keane MP; Strieter RM
    J Biol Chem; 2005 Jun; 280(23):22473-81. PubMed ID: 15802268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer.
    Chang YW; Chen MW; Chiu CF; Hong CC; Cheng CC; Hsiao M; Chen CA; Wei LH; Su JL
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S687-95. PubMed ID: 25047463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells.
    Hsieh YY; Shen CH; Huang WS; Chin CC; Kuo YH; Hsieh MC; Yu HR; Chang TS; Lin TH; Chiu YW; Chen CN; Kuo HC; Tung SY
    J Biomed Sci; 2014 Jun; 21(1):59. PubMed ID: 24929539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis.
    Dayer R; Babashah S; Jamshidi S; Sadeghizadeh M
    J Cancer Res Ther; 2018; 14(2):345-350. PubMed ID: 29516917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Matrine as a Novel Regulator of the CXCR4 Signaling Axis in Tumor Cells.
    Jung YY; Um JY; Narula AS; Namjoshi OA; Blough BE; Kumar AP; Ahn KS
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXCR4 expression is elevated in TNBC patient derived samples and Z-guggulsterone abrogates tumor progression by targeting CXCL12/CXCR4 signaling axis in preclinical breast cancer model.
    Gupta N; Mohan CD; Shanmugam MK; Jung YY; Chinnathambi A; Alharbi SA; Ashrafizadeh M; Mahale M; Bender A; Kumar AP; Putti TC; Rangappa KS; Zhang X; Ahn KS; Sethi G
    Environ Res; 2023 Sep; 232():116335. PubMed ID: 37290620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion.
    Fujimoto D; Hirono Y; Goi T; Katayama K; Matsukawa S; Yamaguchi A
    BMC Cancer; 2010 Aug; 10():443. PubMed ID: 20723226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway.
    Yin X; Liu Z; Zhu P; Wang Y; Ren Q; Chen H; Xu J
    J Cell Biochem; 2019 Jun; 120(6):9724-9736. PubMed ID: 30582214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation.
    Porcile C; Bajetto A; Barbieri F; Barbero S; Bonavia R; Biglieri M; Pirani P; Florio T; Schettini G
    Exp Cell Res; 2005 Aug; 308(2):241-53. PubMed ID: 15921680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.
    Helbig G; Christopherson KW; Bhat-Nakshatri P; Kumar S; Kishimoto H; Miller KD; Broxmeyer HE; Nakshatri H
    J Biol Chem; 2003 Jun; 278(24):21631-8. PubMed ID: 12690099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling.
    Sirinian C; Papanastasiou AD; Schizas M; Spella M; Stathopoulos GT; Repanti M; Zarkadis IK; King TA; Kalofonos HP
    Oncogene; 2018 Sep; 37(37):5101-5114. PubMed ID: 29844572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells.
    Biswas DK; Cruz AP; Gansberger E; Pardee AB
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8542-7. PubMed ID: 10900013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMGA1B/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12/CXCR4 axis-mediated macrophage polarization.
    Tang C; Lei X; Xiong L; Hu Z; Tang B
    Cell Death Dis; 2021 Apr; 12(5):422. PubMed ID: 33927188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosmarinic Acid Analogue-11 Induces Apoptosis of Human Gastric Cancer SGC-7901 Cells via the Epidermal Growth Factor Receptor (EGFR)/Akt/Nuclear Factor kappa B (NF-κB) Pathway.
    Li W; Li Q; Wei L; Pan X; Huang D; Gan J; Tang S
    Med Sci Monit Basic Res; 2019 Feb; 25():63-75. PubMed ID: 30799435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 36. Pyruvate kinase M2 plays a dual role on regulation of the EGF/EGFR signaling via E-cadherin-dependent manner in gastric cancer cells.
    Wang LY; Liu YP; Chen LG; Chen YL; Tan L; Liu JJ; Jazag A; Ren JL; Guleng B
    PLoS One; 2013; 8(6):e67542. PubMed ID: 23840737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
    Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
    Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer.
    Izumi D; Ishimoto T; Miyake K; Sugihara H; Eto K; Sawayama H; Yasuda T; Kiyozumi Y; Kaida T; Kurashige J; Imamura Y; Hiyoshi Y; Iwatsuki M; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Takamori H; Araki N; Tan P; Baba H
    Int J Cancer; 2016 Mar; 138(5):1207-19. PubMed ID: 26414794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The synergistic effects of CXCR4 and EGFR on promoting EGF-mediated metastasis in ovarian cancer cells.
    Guo Z; Cai S; Fang R; Chen H; Du J; Tan Y; Ma W; Hu H; Cai S; Liu Y
    Colloids Surf B Biointerfaces; 2007 Oct; 60(1):1-6. PubMed ID: 17601710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
    Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
    Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.